Danggui-Buxue decoction alleviated vascular senescence in mice exposed to chronic intermittent hypoxia through activating the Nrf2/HO-1 pathway
Open Access
- 10 July 2023
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 61 (1) , 1041-1053
Abstract
As a major risk factor for cardiovascular diseases (CVD), Obstructive sleep apnea (OSA) is characterized by chronic intermittent hypoxia (CIH). Recent studies indicated that the increased cardiovascular risk in patients with OSA may be mediated by accelerated vascular senescence. Danggui-Buxue decoction (DBD) has been used for treating cardiovascular diseases, but its mechanism of vascular senescence regulation is still unclear. To investigate the effect of DBD on vascular senescence in mice exposed to CIH and to explore the role of the Nrf2/HO-1 pathway. C57BL/6N mice were randomly divided into Normoxia control group (CON), CIH (21%-5% O2, 20 times/h, 8 h/d) exposed group (CIH), and DBD treatment group (intragastrically treated with 2.34, 4.68, or 9.36 g/kg/day of DBD separately for 12 weeks as DBL, DBM, or DBH). Blood pressure, cardiac and vascular function, vascular senescence, inflammation response, oxidative stress, and Nrf2/HO-1 expression were determined. DBD (4.68 and 9.36 g/kg) significantly decreased Tail-cuff blood pressure, increased left ventricular systolic function, and alleviated arterial stiffness and vasorelaxation dysfunction in mice exposed to CIH. DBD treatment reduced SA-β-gal activity, decreased p16 (0.68-fold, 0.62-fold), P21 (0.58-fold, 0.52-fold), and p53 expressions (0.67-fold, 0.65-fold), and increased SIRT1 expression (2.22-fold, 2.98-fold) in the aortic. DBD treatment decreased IL-6, NF-κB, and TNF-α expressions, decreased MDA but increased SOD levels, and increased Nrf2 (1.8-fold, 1.89-fold) and HO-1 (2.25-fold, 2.43-fold) expression. DBD could attenuate vascular senescence accelerated by CIH exposure through inhibiting inflammatory response and oxidative stress by activating the Nrf2/HO-1 pathway.Keywords
Funding Information
- Science and Technology Research Fund Project of Hebei Colleges and Universities (142)
- Fundamental Research Funds for the Provisional Universities of Hebei University of Chinese medicine (005)
- Yanzhao Medical Research Project of Hebei University of Chinese medicine (004)
- Graduate Innovation Fund of Hebei University of Chinese Medicine (004)
This publication has 68 references indexed in Scilit:
- Compatibility Study of Danggui Buxue Tang on Chemical Ingredients, Angiogenesis and Endothelial FunctionScientific Reports, 2017
- Ferulic Acid Orchestrates Anti-Oxidative Properties of Danggui Buxue Tang, an Ancient Herbal Decoction: Elucidation by Chemical Knock-Out ApproachPLOS ONE, 2016
- The effect of the severity of obstructive sleep apnea syndrome on telomere lengthOncotarget, 2016
- Danggui Buxue Tang, Chinese Herbal Decoction Containing Astragali Radix and Angelicae Sinensis Radix, Induces Production of Nitric Oxide in Endothelial Cells: Signaling Mediated by Phosphorylation of Endothelial Nitric Oxide SynthasePlanta Medica, 2016
- Uncoupling of Vascular Nitric Oxide Synthase Caused by Intermittent HypoxiaOxidative Medicine and Cellular Longevity, 2016
- A simple practice guide for dose conversion between animals and humanJournal of Basic and Clinical Pharmacy, 2016
- Effects of natural phytochemicals in Angelica sinensis (Danggui) on Nrf2‐mediated gene expression of phase II drug metabolizing enzymes and anti‐inflammationBiopharmaceutics & Drug Disposition, 2013
- Intermittent Hypoxia-Induced NF-κB and HO-1 Regulation in Human Endothelial EA.hy926 CellsCell Biochemistry and Biophysics, 2012
- Origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009Biogerontology, 2009
- Endothelial Dysfunction in Obstructive Sleep ApneaJournal of Clinical Sleep Medicine, 2007